Ta Long Pharmaceutical: Electing Chen Siliang as Chairman and changing the legal representative.

Tai Long Pharmaceuticals announced that the company held its eleventh meeting of the tenth board of directors on July 24, 2026, and reviewed and passed relevant resolutions, electing Chen Siliang as the chairman of the company, with a term of office until the end of the term of the tenth board of directors. As the chairman is the legal representative, the board of directors is authorized to handle business registration changes. In addition, it is agreed to elect Chen Siliang as a member of the Strategic and Development Committee of the tenth board of directors and appoint him as the chairman, with a term of office until the end of the term.